Liposomal Amiodarone Augments Anti-arrhythmic Effects and Reduces Hemodynamic Adverse Effects in an Ischemia/Reperfusion Rat Model
Hiroyuki Takahama(Tohoku University), Tetsuo Minamino(Kagawa University), Naoto Oku(University of Shizuoka), Yoshihiro Asano(National Cerebral and Cardiovascular Center), Masanori Asakura(National Cerebral and Cardiovascular Center), Issei Komuro(University of Tokyo Hospital), Masafumi Kitakaze(Hanwa Memorial Hospital), Shoji Sanada(Kobe University Hospital), Takashi Matsuzaki(The University of Osaka), Keiji Okuda(The University of Osaka), Tomohiro Asai(University of Shizuoka), Hai Ying Fu(National Cerebral and Cardiovascular Center), Masaki Yamato(The University of Osaka), Hirokazu Shigematsu(Dana-Farber Cancer Institute), Hiroshi Asanuma(Meiji University of Integrative Medicine)
Cited by 47
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
|Journal of Clinical Investigation|2007|1k
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
|Cancer Cell|2004|701
Adult Cardiac Sca-1-positive Cells Differentiate into Beating Cardiomyocytes
|Journal of Biological Chemistry|2004|636